A 32-year-old woman (O Rh-negative) is admitted to the emergency department with severe postpartum hemorrhage following vaginal delivery. She has received 4 units of O Rh-positive packed red blood cells in the first hour. Her hemoglobin is now 7.2 g/dL, and she remains hemodynamically unstable. The obstetric team is considering further transfusion. Which of the following is the most appropriate next step regarding blood product selection?

Explanation

## Clinical Context: Rh-Negative Woman in Massive Transfusion This is a life-threatening hemorrhage scenario where the patient has already received 4 units of Rh-positive blood. The priority shifts from preventing sensitization to saving maternal life, while still mitigating future alloimmunization risk. ### Key Point: **In massive transfusion, preventing exsanguination takes precedence over preventing alloimmunization.** Once Rh-positive blood has been transfused to an Rh-negative woman, further Rh-positive transfusions do not substantially increase the risk of sensitization beyond what has already occurred. Switching to Rh-negative blood is ideal *if available*, but should not delay life-saving transfusion. ### Why Option D is Correct: - If O Rh-negative blood is unavailable, continuing O Rh-positive blood is acceptable in a life-threatening emergency. - Anti-D immunoglobulin (Rh immunoglobulin) should be administered to reduce the risk of alloimmunization and protect future pregnancies from hemolytic disease of the newborn (HDN). - The **window of opportunity for anti-D prophylaxis is 72 hours** post-exposure, so prompt administration is important but does not preclude further Rh-positive transfusions. ### High-Yield — Anti-D Dosing (RCOG/ACOG Guidelines): - Standard antenatal/postnatal prophylaxis: **500 IU (100 µg)** covers up to **4 mL of fetal red blood cells** (or 8 mL fetal whole blood). - For larger fetomaternal hemorrhage or inadvertent Rh-positive transfusion: dose is calculated as **500 IU per 4 mL fetal RBCs** (i.e., ~125 IU per mL of fetal RBCs), with additional doses given based on Kleihauer-Betke test or flow cytometry quantification. - For adult Rh-positive RBC transfusion to an Rh-negative recipient: approximately **20 µg (100 IU) per mL of Rh-positive RBCs transfused** is recommended (ACOG/AABB). ### Why Other Options Are Wrong: - **Option A (Cross-match first):** In life-threatening hemorrhage, waiting for cross-match is inappropriate; emergency release of O-negative or O-positive blood is standard. - **Option B (Continue Rh-positive as universally compatible):** O Rh-positive is NOT universally compatible — it is incompatible for Rh-negative individuals who may develop anti-D antibodies. This statement is factually incorrect. - **Option C (Switch to Rh-negative immediately):** While preferable, this option implies Rh-negative is available and ignores the need for anti-D prophylaxis for the already-administered Rh-positive units. It is incomplete as a management strategy. ### Clinical Pearl: **The correct answer (D) reflects real-world massive transfusion protocol:** prioritize survival, use Rh-negative blood when available, administer anti-D within 72 hours, and do not withhold life-saving Rh-positive blood if Rh-negative is unavailable. [cite: RCOG Green-top Guideline No. 22 (Anti-D Prophylaxis); ACOG Practice Bulletin No. 181; Harrison's Principles of Internal Medicine, 21e, Ch. 179]